Comparison of previous and present World Health Organization clinical staging criteria in HIV-infected Malawian children

AIDS

Volumn 23, Issue 14, 2009, Pages 1913-1916

  Poerksen, Goenke ^a   Nyirenda, Maggie ^a   Pollock, Louisa ^a   Blencowe, Hannah ^a   Tembo, Paul ^a   Chesshyre, Emily ^a   Jefferis, Oliver ^a   Kenny, Julia ^a   Moons, Peter ^a   Bunn, James ^a   Molyneux, Elizabeth ^a  

^a QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALAWI; MALE; VIRAL LOAD; WORLD HEALTH ORGANIZATION;

EID: 70249102826     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832f7b39     Document Type: Article

References (18)

1. Epidemiological fact sheets, Malawi, update 2006. http:// www.who.int/GlobalAtlas/predefinedReports/EFS2006/ EFS-PDFs/EFS2006MW (accessed 17 March 2007).
2. Malawi Paediatric Antiretroviral Treatment Group. Antiretro-viral therapy for children in the routine setting in Malawi. Trans R Soc Trop Med Hyg 2007; 101:511-516.
3. World Health Organisation. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access, 2007. http://www.who.int/hiv/pub/guidelines/paediatric020907 (accessed 17 April 2009).
4. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008; 8: 477-489.
5. World Health Organisation. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. 2003; http://whqlibdoc.who.int/publications/2004/ 9241591552.pdf (accessed 17 April 2009).
6. UNICEF/WHO Technical consultation: improving access to appropriate paediatric ARV formulations. November 2004; http://www.who.int/3by5/en/ finalreport.pdf (accessed 17 April 2009).
7. World Health Organisation. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. http://www.who.int/hiv/pub/guidelines/ HIVstaging150307.pdf (accessed 17 April 2009).
8. Chintu C. Tuberculosis and human immunodeficiency virus co-infection in children: management challenges. Paediatr Respir Rev 2007; 8:142-147.
9. Zar HJ. Pneumonia in HIV-infected and HIV-uninfected children in developing countries: epidemiology, clinical features, and management. Curr Opin Pulm Med 2004; 10:176-182.
10. HIV Paediatric Prognostic Markers Collaboration Study. Use of total lymphocyte count for informing when to start antiretro-viral therapy in HIV-infected children: a meta-analysis of longitudinal data. Lancet 2005; 366:1868-1874.
11. Bobat R, Coovadia H, Moodley D, Coutsoudis A, Gouws E. Growth in early childhood in a cohort of children born to HIV-1 infected mothers from Durban, South Africa. Ann Trop Paediatr 2001; 21:203-210.
12. Galli L, de Martino M, Tovo PA, Gabiano C, Zappa M, Giaquinto C, et al. Onset of clinical signs in children with HIV-1 perinatal infection. Italian register for HIV infection in children. AIDS 1995; 9:455-461.
13. Morris CR, Araba-Owoyele L, Spector SA, Maldonado YA. Disease patterns and survival after acquired immunodeficiency syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1996; 15:321-328.
14. Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, Chintu C, et al. Determinants of survival without antiretroviral therapy after infancy in HIV-1 infected Zambian children in the CHAP trial. J Acquir Immune Defic Syndr 2006; 42:637-645.
15. Banda T. Infant feeding and children's and women's nutritional status. Malawi Demographic and Health Survey 2004. National Statistical Office Zomba, Malawi and ORC Macro Calverton, Maryland, USA. pp. 187-482, chapter 10.
16. Elenga N, Kouakoussui KA, Bonard D, Fassinou P, Anaky M-F, Wemin M-L, et al. Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire. Pediatr Infect Dis J 2005; 24:1077-1082. (Pubitemid 43011064)
17. Ryan CT. Concurrent ART/TB treatment finally proven to be beneficial. AIDS Clin Care 2008; 20:89.
18. Violari A, Cotton M, Gibb D. Antiretroviral therapy initiated before 12 weeks of age reduces early mortality in young HIV-infected infants; evidence from the Children with HIV Early Antiretroviral Therapy (CHER) study (Abstract WESS103). Proceedings of the fourth IAS Conference on HIV Patho-genesis, Treatment, and Prevention; 22-25 July 2007; Sydney, Australia. http://www.ias2007.org/pag/Abstracts.aspx?AID= 5557 (accessed 20 August 0 2008).